2DAVIDSON N C, STRUTHERS A D. Brain natfiuretic peptide [ J]. Hypertens, 1994, 12:329 - 336.
3[1]Ridker P M, Cushman M, Stampfre MJ, et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular. Circulation, 1998, 97:425.
4[2]Ridker PM, Rifai N, Pfeffer MA, et al. Inflammation, pravastatin and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Circulation, 1998, 98(9):839.
5[3]Anzai T, Yoshikawa T, Shiraki H, et al. C-Reactive protein as a predictor of expansin and cardiac rupture after a first Q-wave acute myocardial infarction. Circulation, 1997,96(3):778.
6[4]Arakawa N, Nakamura M, A oki H, et al. Relationship between plasma level of brain natruretic peptide and myocardial infarct size. Cardiology 1994, 85:334.
7[5]Nicholls MG. The natriuretic peptides in heart failure. J Intern Med, 1994, 235:515.
8[6]Alberola AM, Revert F, Moya A, et al. Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion. J Gen Pharmacol, 2000, 35(3):143.
9[1]Cowie MR,Mendez GF.BNP and congestive heart failure.Prog cardiovasc Dis,2002,44:293-321.
10[3]Luchner A, Stevens TL,Borgeson DD,et a1. Differential atria and ventricular expression of myocardial BNP during evolution of heart failure.Am J Physiol,1998,274:H1684-1689.
